Maximus, Inc. (NYSE:MMS) Short Interest Update

Maximus, Inc. (NYSE:MMSGet Rating) was the recipient of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 1,310,000 shares, a decline of 23.8% from the March 31st total of 1,720,000 shares. Currently, 2.1% of the shares of the company are sold short. Based on an average daily volume of 413,800 shares, the days-to-cover ratio is currently 3.2 days.

A number of hedge funds have recently bought and sold shares of the stock. Victory Capital Management Inc. lifted its holdings in Maximus by 9.1% in the fourth quarter. Victory Capital Management Inc. now owns 4,604,112 shares of the health services provider’s stock worth $366,810,000 after purchasing an additional 383,810 shares during the period. Alliancebernstein L.P. lifted its holdings in Maximus by 6.2% in the 4th quarter. Alliancebernstein L.P. now owns 3,339,698 shares of the health services provider’s stock valued at $266,074,000 after acquiring an additional 193,816 shares during the last quarter. Mackenzie Financial Corp boosted its position in shares of Maximus by 3.1% during the 4th quarter. Mackenzie Financial Corp now owns 2,679,821 shares of the health services provider’s stock valued at $213,501,000 after purchasing an additional 81,037 shares in the last quarter. Pictet Asset Management SA grew its stake in shares of Maximus by 1.6% in the 4th quarter. Pictet Asset Management SA now owns 1,439,782 shares of the health services provider’s stock worth $114,707,000 after purchasing an additional 22,925 shares during the last quarter. Finally, Janus Henderson Group PLC raised its holdings in shares of Maximus by 0.5% in the 3rd quarter. Janus Henderson Group PLC now owns 1,248,378 shares of the health services provider’s stock worth $103,865,000 after purchasing an additional 5,912 shares in the last quarter. 93.54% of the stock is owned by institutional investors and hedge funds.

MMS has been the subject of a number of research reports. StockNews.com initiated coverage on shares of Maximus in a report on Thursday, March 31st. They issued a “hold” rating for the company. Zacks Investment Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating and set a $86.00 price target for the company. in a report on Thursday, April 7th.

Shares of MMS opened at $72.88 on Monday. Maximus has a 1 year low of $72.04 and a 1 year high of $94.79. The company has a market cap of $4.51 billion, a price-to-earnings ratio of 16.27 and a beta of 0.73. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a fifty day moving average of $75.56 and a 200-day moving average of $78.15.

Maximus (NYSE:MMSGet Rating) last announced its quarterly earnings results on Thursday, February 3rd. The health services provider reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.32. The company had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Maximus had a net margin of 6.29% and a return on equity of 22.04%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 earnings per share. Analysts predict that Maximus will post 5.23 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 31st. Investors of record on Friday, May 13th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.54%. The ex-dividend date is Thursday, May 12th. Maximus’s payout ratio is currently 25.00%.

About Maximus (Get Rating)

Maximus, Inc provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S.

See Also

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.